This is a Phase 3b/Phase 4 study. The purpose of this study is to learn more about the efficacy of using CBD-OS as an add-on therapy for the treatment of LGS i…

Lennox-Gastaut Syndrome

~Estimated

~$10 – $8,750

Jazz PharmaceuticalsNCT07728097

Phase 1

Preliminary Evaluation of the Safety and Efficacy of CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in Individuals Diagnosed with Dravet Syndrome And/or Lennox-Gastaut Syndrome

This study is a preliminary open-label, single-arm Phase II investigation into the safety and efficacy of transdermal cannabidiol (CBD) delivered using GT4 ski…

Lennox-Gastaut Syndrome (LGS)Dravet Syndrome (DS)

~Estimated

~$10 – $7,500

Alexander RotenbergNCT06738732